n/a
Abstract Title:

Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardio-metabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial.

Abstract Source:

Appl Physiol Nutr Metab. 2018 Jan 9. Epub 2018 Jan 9. PMID: 29316405

Abstract Author(s):

Maryam Karamali, Shahla Bahramimoghadam, Fateme Sharifzadeh, Zatollah Asemi

Article Affiliation:

Maryam Karamali

Abstract:

To the best our knowledge, data on the effects of magnesium-zinc-calcium-vitamin D co-supplementation on glycemic control and markers of cardio-metabolic risk in gestational diabetes mellitus (GDM) are scarce. The purpose of this study was to establish the effects of magnesium-zinc-calcium-vitamin D co-supplementation on glycemic control and markers of cardio-metabolic risk of GDM patients. Sixty patients with GDM, aged 18-40 years old were randomised into two groups to intake either magnesium-zinc-calcium-vitamin D co-supplements or placebo (n=30 each group) for 6 weeks in a randomized, double-blind, placebo-controlled trial. Fasting blood samples were taken at baseline and week 6 to quantify related markers. After the 6-week intervention, compared with the placebo, magnesium-zinc-calcium-vitamin D co-supplementation supplementation resulted in significant reductions in fasting plasma glucose (-0.37±0.09 vs. +0.01±0.09 mmol/L, P=0.003), serum insulin levels (-21.0±4.8 vs. +7.2±4.8 pmol/L, P<0.001), homeostatic model of assessment for insulin resistance (-1.0±1.1 vs. +0.3±1.3, P<0.001), and a significant increase in quantitative insulin sensitivity check index (+0.02±0.03 vs. -0.002±0.03, P=0.003). In addition, magnesium-zinc-calcium-vitamin D co-supplementation significantly decreased serum triglycerides (-0.25±0.10 vs. +0.34±0.10 mmol/L, P=0.001) and VLDL-cholesterol concentrations (-0.11±0.04 vs. +0.15±0.04 mmol/L, P=0.001) compared with the placebo. Overall, the results of this study demonstrated that magnesium-zinc-calcium-vitamin D co-supplementation for 6 weeks among patients with GDM had beneficial effects on glycemic control and few markers of cardio-metabolic risk.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.